Latest Healthcare News

Page 80 of 138
Universal Biosensors Inc. has been suspended from ASX trading following the appointment of voluntary administrators, highlighting serious financial distress within the company.
Ada Torres
Ada Torres
22 Aug 2025
The ASX has suspended the securities of 36 companies for failing to pay their annual listing fees by the August 21 deadline, with a looming delisting threat if fees remain unpaid by August 28.
Victor Sage
Victor Sage
22 Aug 2025
Monash IVF Group reported steady FY25 financial results with revenue and EBITDA growth, while managing clinical incidents and a CEO transition. The company outlines cautious FY26 guidance amid industry headwinds.
Ada Torres
Ada Torres
22 Aug 2025
Zip Co has delivered a standout FY25 with cash earnings soaring 147%, driven by rapid US market expansion. The company is now considering a Nasdaq dual listing to fuel further growth.
Claire Turing
Claire Turing
22 Aug 2025
Cogstate Limited reported a 22.3% rise in total revenue to US$53.1 million for FY25, driven by strong Clinical Trials growth, while profit before tax nearly doubled to US$13.9 million. The company also declared its inaugural fully franked dividend.
Ada Torres
Ada Torres
22 Aug 2025
Atomo Diagnostics reports a significant expansion in its supply agreement with Lumos for the Pascal test cassette, tied to the promising CLIA waiver status of the FebriDx test in the US. This deal could nearly double Atomo’s revenues over the next three years.
Ada Torres
Ada Torres
21 Aug 2025
Healius Limited reported a 5.7% rise in FY25 revenue driven by pathology growth, while underlying EBIT fell 27% impacted by cyclone disruptions and restructuring. The company advances its pathology strategy and cost savings post-Lumus divestment.
Ada Torres
Ada Torres
21 Aug 2025
Healius reported a 5.7% rise in FY25 revenue with underlying EBIT meeting consensus, buoyed by strong pathology growth and a significant profit from the Lumus Imaging sale. Despite challenges at Agilex Biolabs and a major goodwill impairment, the company targets improved margins by 2027.
Ada Torres
Ada Torres
21 Aug 2025
Sonic Healthcare has delivered solid FY 2025 results, meeting EBITDA guidance with 5% organic revenue growth and setting the stage for up to 19% EPS growth in FY 2026, driven by strategic acquisitions and operational synergies.
Ada Torres
Ada Torres
21 Aug 2025
Sonic Healthcare delivered solid FY2025 results with 8% revenue growth and a 7% rise in net profit, setting the stage for an anticipated 19% earnings per share increase in FY2026.
Ada Torres
Ada Torres
21 Aug 2025
Sonic Healthcare Limited has announced an ordinary dividend of AUD 0.63 per share for the first half of 2025, with a 35% franking component and payment scheduled for mid-September.
Ada Torres
Ada Torres
21 Aug 2025
Medical Developments International has reported a remarkable turnaround in FY25, posting a net profit after tax and securing paediatric approval for its flagship product Penthrox in Europe.
Ada Torres
Ada Torres
21 Aug 2025